| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.009 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |